Final Price Paid Not Disclosed — But Celgene Closes On Legacy S-P Facility: 556 Morris Ave., Summit, NJ

In due course, if I remember to spend a little time looking it through — I’ll try to figure out an approximate final price, from the tax bills, online in NJ — or Celgene’s SEC filings, but the sale of the legacy Organon/Schering-Plough Morris Aveneue has now closed. We have covered the various Morris Ave. property shuffles, since early 2009.

And at least somewhat as irony would have it, Carrie S. Cox — a Fred Hassan protégé, once again (this time as a director) has a hand in the control of this site. Here is a bit from the local news outlet:

. . . .Celgene Corp. has completed its purchase of the former Merck & Co. research and development complex in Summit, giving a new lease on life to the 1.3 million-square-foot campus as the biotech giant continues its expansion in the city. . . .

Onward — hoping that my Cubbies will ultimately meet the Mets, in a few days. A reversal of 1969, that would be. . . smile.


There are no comments on this post.

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s

%d bloggers like this: